November 15, 2023 | Client News
FORT LAUDERDALE, FL, Nov. 14, 2023 (GLOBE NEWSWIRE) — via NewMediaWire –Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, today reported financial results for the third quarter period ended September 30, 2023. Investors are encouraged to read the Company’s quarterly report on Form 10-Q which was filed with […]
November 15, 2023 | Client News
SHELTON, CT / ACCESSWIRE / November 15, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal first quarter ending September 30, 2023 with the Securities and Exchange Commission (SEC) on Tuesday, November 14, 2023. The report can be accessed at the SEC website […]
November 15, 2023 | Client News
Phase IIa trial outcome indicates the potential for a new way to help Alzheimer’s patients’ agitation Tel-Aviv, Nov. 15, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), unveiled positive topline results from […]
November 15, 2023 | Client News
Nashville, TN, Nov. 15, 2023 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, and American Rebel Beer, announced its financial results for the three- and nine-month periods ended September 30, 2023. Investors are encouraged […]
November 14, 2023 | Client News
SHELTON, CT / ACCESSWIRE / November 14, 2023 / NanoViricides, Inc. (AMEX:NNVC) (the “Company”), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reports that its broad-spectrum antiviral drug candidate, NV-387 was highly effective in an animal model that is used in drug development for MPox and Smallpox virus infections in […]
November 14, 2023 | Client News
Total revenues for the third quarter of 2023 of approximately $11.4 million, representing an 94.8% increase over the comparable period in 2022 Gross profit grew to approximately $2.7 million, up 216.6% from $0.8 million in the comparable period in 2022. NEW YORK, NY, Nov. 13, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Applied UV, Inc. (NASDAQ: AUVI), […]
November 14, 2023 | Client News
NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) — DSS, Inc. (NYSE American: DSS) announced today that, in a unanimous decision, the Court of Appeals for the Federal Circuit (CAFC) rejected Nichia Corp.’s challenge to U.S. Patent No. 6,879,040 (the ‘040 Patent). U.S. Chief Circuit Judge Kimberly Moore, who authored the opinion, and U.S. Circuit Judges […]
November 13, 2023 | Client News
FORT WORTH, TX / ACCESSWIRE / November 10, 2023 / Sadot Group Inc. (Nasdaq:SDOT) (the “Sadot Group” or the “Company”), an emerging player in the global food supply chain sector, today announced that the Company plans to file their results for the quarter ending September 30, 2023, on Tuesday November 14th, 2023. Sadot Group Inc. will then […]
November 13, 2023 | Client News
Extended Follow Up Data Show Continued, Transplant Free Survival of All Patients Results Support Continued Investigation of Lomecel-BTM As Adjunct to Stage II Surgery in HLHS – Enrollment ongoing in Phase 2 ELPIS II trial – MIAMI, Nov. 11, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or “Company”), a clinical-stage biotechnology company […]